2024-02-14 | NDAQ:GLSI | Press Release | Greenwich Lifesciences Inc
(2024-02-14 | NDAQ:GLSI) Greenwich LifeSciences Provides Update on Phase III Clinical Trial, Flamingo-01
Source: stockhouse.com
Jaye Thompson News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Jaye Thompson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Jaye Thompson Today - Breaking & Trending Today
COMMENTARY: Hats off RWRRV for informative meeting
At a time when people in our community are suffering from the devastation of the Nov. 4 tornado, the Thursday night meeting of the Republican Women of the Red River
Source: theparisnews.com
Greenwich LifeSciences Presents Immune Response Phase IIb Poster, Published Today at AACR 2021, Showing Peak Immunity after 6 Months of GP2 Treatment, Resulting in 100% Disease Free Survival from Recurring Breast Cancer
STAFFORD, Texas--(BUSINESS WIRE)--Apr 10, 2021-- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the âCompanyâ), a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery, today presented a poster of the final 5 year GP2 Phase IIb clinical trial immune response data at the 2021 AACR Annual Meeting. Immune response is the primary mechanism of action for GP2 and is critical to developing dosing and booster treatment strategies that are designed to achieve and sustai...
Source: kdhnews.com